Panacea Biotec Chairman Soshil Kumar passes away at age of 89

Published On 2022-10-10 06:04 GMT   |   Update On 2022-10-10 06:04 GMT

New Delhi: Panacea Biotec Ltd founder and chairman Soshil Kumar Jain passed away on October 7, Friday, at the age of 89.

According to a regulatory filing by the company, Jain (89), who had been admitted to the Medanta Hospital for the last ten days, suffered a cardiac arrest on Friday afternoon.

Informing BSE about his demise, Panacea Biotec said, "Soshil Kumar Jain's sudden and unexpected passing away will be an irreparable loss to the company."

Advertisement

Read also: Panacea Biotec, CEPI, THSTI partner to develop broadly protective Betacoronavirus vaccines

The directors and employees convey deep sympathy, sorrow, and condolences to his bereaved family members, it added.

Soshil Kumar was a Qualified Pharmacist. He was also a director of PanEra Biotec Pvt. Ltd., Neophar Alipro Ltd., Adveta Power Pvt. Ltd. (formerly known as Advaita Power Ventures Pvt. Ltd.) and White Pigeon Estate Pvt. Ltd.

The patriarch of promoter family of Panacea Biotec Ltd, Jain had founded the company in 1984 as Panacea Drugs Pvt Ltd, and when the company was publicly listed on the Indian stock exchanges in September 1995, its name changed to Panacea Biotec Ltd. It is among the major vaccine manufacturing companies in the country.

Read also: Panacea Biotec director Shantanu Yeshwant Nalavadi resigns

Tags:    
Article Source : with inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News